The global glucose monitoring devices market size was valued at USD 13.88 billion in 2025 and is projected to grow from USD 14.66 billion in 2026 to USD 22.72 billion by 2034, registering a CAGR of 5.63% during the forecast period from 2026 to 2034. North America dominated the glucose monitoring devices market with a market share of 39.4% in 2025.
The glucose monitoring devices comprises medical devices and technologies used to measure and monitor blood glucose levels in individuals with diabetes and other metabolic disorders. The market includes continuous glucose monitoring (CGM) systems, self-monitoring blood glucose (SMBG) meters, test strips, lancets, and related accessories. Growth is driven by the rising prevalence of diabetes, increasing adoption of wearable monitoring technologies, advancements in digital healthcare, and growing awareness of proactive glucose management for improved patient outcomes.
Download a Free Sample To learn more about this report,
Shift Toward Wearable and Continuous Glucose Monitoring
The glucose monitoring devices market is moving from intermittent fingerstick testing toward wearable systems that provide continuous or near-continuous glucose information. These devices improve visibility into glucose fluctuations, enabling users and healthcare professionals to assess trends, time in range, and changes associated with meals, physical activity, and treatment. The increasing integration of sensors with smartphones and digital platforms is further strengthening the role of continuous monitoring in routine diabetes management.
In June 2026, the U.S. Food and Drug Administration cleared an over-the-counter continuous glucose monitoring system for children aged two years and older who do not use insulin, expanding wearable glucose monitoring beyond traditional prescription-based use.
Expansion of Multi-Analyte and Advanced Sensor Monitoring
Glucose monitoring devices are increasingly incorporating additional physiological measurements and more advanced sensing capabilities rather than focusing solely on glucose readings. Combining glucose information with other metabolic indicators can provide earlier warning of potential complications and support more comprehensive monitoring. This development is broadening the functional scope of glucose monitoring devices and encouraging manufacturers to pursue higher-value sensor platforms.
In August 2026, the U.S. Food and Drug Administration authorized the first wearable system in the country capable of continuously monitoring both glucose and ketone levels, allowing users to receive simultaneous metabolic information through a single device.
Rising Global Diabetes Burden Supports Demand for Glucose Monitoring
The growing number of people living with diabetes is expanding the population requiring regular glucose assessment and long-term disease management. Glucose monitoring devices help patients evaluate blood glucose patterns and support treatment decisions, making monitoring an essential component of diabetes care. As diabetes prevalence increases across both developed and developing economies, the addressable user base for glucose meters, sensors, and continuous monitoring systems is also expanding.
In November 2024, the World Health Organization reported that the global number of adults living with diabetes had reached approximately 830 million in 2022, compared with about 200 million in 1990.
High Out-of-Pocket Costs Limit Adoption Among Uninsured Users
The cost of sensors, transmitters, readers, test strips, and replacement supplies can restrict access to glucose monitoring technologies, particularly when reimbursement is unavailable. Continuous monitoring systems can require recurring purchases, making long-term use more expensive than one-time device acquisition. These financial barriers can slow adoption among patients with limited insurance coverage or constrained healthcare budgets.
In September 2025, the U.S. Centers for Disease Control and Prevention reported that continuous glucose monitors can cost thousands of dollars annually without insurance coverage, highlighting the financial barrier associated with sustained device use.
Integration of Glucose Monitoring With Remote Diabetes Care
Connecting glucose monitoring devices with telehealth platforms and remote-care programs creates opportunities for healthcare providers to review patient-generated data without requiring frequent in-person visits. Automated data transmission can help clinicians identify changing glucose patterns and support earlier treatment adjustments. Greater integration between monitoring devices, digital health platforms, and virtual diabetes services can therefore expand utilization beyond conventional self-monitoring.
In June 2025, a multicenter community-based study published in a peer-reviewed medical journal evaluated remote glucose monitoring among newly diagnosed patients with type 2 diabetes, supporting continued development of technology-enabled diabetes management models.
Maintaining Sensor Accuracy and Patient Safety Remains Critical
Glucose monitoring devices directly influence treatment decisions, making measurement accuracy and reliable alerts essential for patient safety. Sensor errors can produce misleading glucose values and potentially result in inappropriate insulin dosing, delayed treatment, or other harmful decisions. Manufacturers and regulators therefore face the ongoing challenge of maintaining accuracy across different users, environments, sensor wear periods, and device generations.
In January 2026, the U.S. Food and Drug Administration reported that a recall involving certain continuous glucose monitoring sensors had been associated with incorrect glucose readings, including reports of serious injuries and deaths, reinforcing the importance of sensor reliability and quality control.
Self-monitoring Devices Dominated the Market with 58.7% Share in 2025
The Self-monitoring Devices segment accounted for the largest share of the global Glucose Monitoring Devices Market at 58.7% in 2025, driven by their widespread use among diabetic patients for routine blood glucose testing, affordability, and ease of use. Strong demand for portable monitoring devices, increasing awareness of diabetes self-management, and growing availability of user-friendly glucometers continue to support the segment's market leadership across both developed and emerging healthcare markets.
Request Customizationto receive a tailored report.
Type 1 Diabetes is Projected to Register the Fastest Growth at a CAGR of 9.7%
The Type 1 Diabetes segment is expected to expand at the fastest CAGR of 9.7% during 2026–2034, supported by rising adoption of continuous glucose monitoring (CGM) systems, increasing prevalence of autoimmune diabetes, and growing emphasis on maintaining tight glycemic control. Technological advancements in wearable glucose monitoring devices and improved reimbursement policies are further accelerating market growth within this segment.
Home Care Settings Dominated the Market with 57.9% Share in 2025
The Home Care Settings segment held the largest market share of 57.9% in 2025, owing to the increasing preference for home-based diabetes management, rising adoption of portable glucose monitoring devices, and the growing need for continuous health monitoring outside clinical settings. Improved patient convenience, expansion of telehealth services, and greater awareness of preventive diabetes care continue to strengthen the segment's dominant position.
Speak to an Analystto discuss market opportunities.
Asia Pacific accounted for 22.8% of the market, reaching USD 3.16 billion in 2025. The region is projected to register the fastest growth at a CAGR of 10.9% during the forecast period. Growth is supported by expanding healthcare infrastructure, rising healthcare expenditure, increasing adoption of advanced medical technologies, and growing investments in healthcare modernization. Improving access to specialized healthcare services and rapid technological advancements continue to strengthen regional market expansion.
China accounted for an estimated USD 1.34 billion in 2025, making it the largest market in Asia Pacific. Growth is driven by expanding healthcare infrastructure, increasing government investments, rising domestic manufacturing capabilities, and growing adoption of advanced medical technologies.
Japan generated an estimated USD 0.73 billion in 2025. The country's advanced healthcare system, aging population, increasing healthcare expenditure, and continuous adoption of innovative medical technologies continue to support steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
North America dominated the market with a 39.4% market share, valued at USD 5.47 billion in 2025. The region benefits from advanced healthcare infrastructure, high healthcare expenditure, favorable reimbursement policies, and strong research and development activities. Increasing adoption of innovative medical technologies and the presence of leading industry participants continue to drive market growth.
The United States accounted for an estimated USD 4.52 billion of the market in 2025, making it the largest contributor in North America. Growth is driven by increasing healthcare spending, strong clinical research activities, widespread adoption of advanced medical technologies, and continuous product innovation.
Canada generated an estimated USD 0.63 billion in 2025. Rising government healthcare expenditure, increasing investments in medical research, expanding access to advanced healthcare services, and growing adoption of innovative healthcare technologies continue to support market growth.
Europe accounted for 27.1% of the market, reaching USD 3.76 billion in 2025. The market is supported by well-established healthcare systems, increasing investments in medical innovation, favorable regulatory frameworks, and growing demand for advanced healthcare solutions. Continuous research activities and healthcare modernization initiatives are contributing to regional expansion.
Germany led the European market with an estimated value of USD 1.09 billion in 2025. The country's advanced healthcare infrastructure, strong medical technology industry, increasing research investments, and high healthcare expenditure continue to drive market growth.
The United Kingdom represented an estimated USD 0.64 billion in 2025. Growth is driven by increasing NHS investments in healthcare innovation, expanding adoption of advanced healthcare technologies, and rising clinical research activities.
Latin America accounted for 6.2% of the market, reaching USD 0.86 billion in 2025. Rising healthcare expenditure, improving access to specialized healthcare services, expanding healthcare infrastructure, and increasing awareness of advanced treatment solutions are supporting regional market growth.
Brazil accounted for an estimated USD 0.45 billion in 2025, making it the largest market in Latin America. Increasing investments in healthcare infrastructure, expanding private healthcare services, and growing adoption of advanced medical technologies continue to support market expansion.
The Middle East & Africa represented 4.5% of the market, totaling USD 0.62 billion in 2025. Increasing investments in healthcare infrastructure, expanding access to specialized healthcare services, growing adoption of advanced medical technologies, and government initiatives to modernize healthcare systems are supporting regional market growth.
The United Arab Emirates (UAE) accounted for an estimated USD 0.17 billion in 2025. The country's market is driven by government investments in healthcare modernization, expanding private hospital networks, increasing medical tourism, and growing adoption of innovative healthcare technologies.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Bronchoscopes Market Size, Share, Growth, Analysis, Report, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
Bladder Scanners Market Size, Share, Growth, Forecast, 2034
Japan Dialyzer Market Size, Top Share, Demand And Forecast to 2034
We are featured on:
sales@straitsresearch.com